Persistent Type I Interferon Signaling Impairs Innate Lymphoid Cells During HIV-1 Infection Under Suppressive ART
Viruses · 2025
DOI: 10.3390/v17081099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Runpeng Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology and Biosafety, Department of Infectious Diseases, Medical Research Institute, Frontier Science Center for Immunology…. Hauptthemen laut MEDLINE: Interferon Type I, Immunity, Innate, HIV Infections, HIV-1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Natural Science Foundation of China, NIDDK NIH HHS.
Abstract (Originalsprache)
Persistent type I interferon (IFN-I) signaling compromises adaptive anti-HIV-1 T cell immunity and promotes viral reservoir persistence, yet its effects on innate lymphoid cells during chronic infection remain unclear. Through integrated single-cell RNA sequencing and functional validation in HIV-1-infected humanized mice with combination antiretroviral therapy (cART) and IFN-I signaling blockade, we reveal IFN-I-induced dysfunction of natural killer (NK) cells and group 3 innate lymphoid cells (ILC3s). Mechanistically, the IFN-I-CD9 axis drives NK cells toward a decidual NK cell-like phenotype, impairing their cytotoxic activity. Furthermore, IFNAR blockade rescues ILC3 functionality, which is critical for IL-17/IL-22-mediated antimicrobial defense and mucosal barrier maintenance. Our study delineates IFN-I-driven immunosuppression across innate lymphocyte compartments and proposes the targeted modulation of this pathway to enhance antiviral and mucosal immunity in HIV-1 management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Virology and Biosafety, Department of Infectious Diseases, Medical Research Institute, Frontier Science Center for Immunology and Metabolism, Zhongnan Hospital of Wuhan University, Wuhan Universi…
- Lineberger Comprehensive Cancer Center, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
- Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
- Division of Virology, Pathogenesis, and Cancer, Institute of Human Virology, Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- Center for AIDS Research, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
ORCID-Profile: Runpeng Han, Haisheng Yu, Lishan Su
Förderung
- NIH HHS
- National Natural Science Foundation of China
- NIDDK NIH HHS
- Fundamental Research Funds for the Central Universities
- NIAID NIH HHS
- National Key R&D Program
- National Key R&D Program
- National Institutes of Health
Zitieren
APA
Han, R., Yu, H., Li, G., Su, L., & Cheng, L. (2025). Persistent Type I Interferon Signaling Impairs Innate Lymphoid Cells During HIV-1 Infection Under Suppressive ART. Viruses. https://doi.org/10.3390/v17081099
Vancouver
Han R, Yu H, Li G, Su L, Cheng L. Persistent Type I Interferon Signaling Impairs Innate Lymphoid Cells During HIV-1 Infection Under Suppressive ART. Viruses. 2025. doi:10.3390/v17081099
BibTeX
@article{Han2025,
author = {Han, Runpeng and Yu, Haisheng and Li, Guangming and Su, Lishan and Cheng, Liang},
title = {Persistent Type I Interferon Signaling Impairs Innate Lymphoid Cells During HIV-1 Infection Under Suppressive ART},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17081099}
}
EUVIMED